This laboratory study examines the MC-2 peptide’s association with reduced liver injury following rescuscitated hemorrhagic shock in rats.
This study of patients undergoing hepatopancreaticobiliary surgery reports significant variability in hospital costs associated with patient and hospital characteristics.
This Viewpoint discusses the current liver allocation policy, which has led to increasing geographic disparity in access to liver transplantation across the United States.
This Viewpoint discusses the benefits of the associating liver partition and portal vein ligation for staged hepatectomy approach for treating liver tumors.
This Viewpoint discusses the associating liver partition and portal vein ligation (ALPPS) procedure vs portal vein embolization for safe and effective generation of future liver remnant hypertrophy for hepatectomy.
In this prospective study, the economic impact of using liberal vs restrictive blood transfusion triggers in patients undergoing pancreas, liver, or colorectal surgery is assessed.
A 20-year-old woman had small free fluid within the pelvis and 2 large mesenteric masses adjacent to the liver, pancreas, and stomach. What is your diagnosis?
This retrospective analysis shows that liver transplantation is a valid therapeutic option in selected patients with benign solid liver tumors who are not amenable to resection.
This experimental rat model study of hemorrhage provides a foundation to design novel nonsurgical therapies to control hemorrhage and allows flexibility in experimental design.
Hong et al compare long-term outcomes for children (aged ≤18 years) undergoing orthotopic liver transplantation using grafts from donation after circulatory death and donation after brain death.
In a retrospective analysis, Fischer et al determine whether the administration of chemotherapy mitigates tumor growth after portal vein embolization that is performed before major hepatectomy for metastatic colorectal cancer.
Schwartz and colleagues examined whether the 16-hour intern work limit, implemented in July 2011, has adversely affected operative experience. Julie Ann Freischlag, MD, provides an invited commentary.